EarningsQ1 2024 Earnings Report

Novavax (NVAX) Q1 2024 Earnings Report

0 Followers

MX:NVAX Q1 2024 EPS Results

Actual EPS-$19.33

Consensus EPS-$19.59

Beat/MissBeat by +$0.26

One Year Ago EPS-$62.79

Actual Revenue$1.73B

Expected Revenue$1.86B

Beat/MissMissed by -$134.52M

YoY Revenue Growth+15.94%

QuarterQ1 2024

Date05/10/2024

TimeBefore Open

Conference CallFriday, May 10, 2024

MX:NVAX Upcoming Earnings

Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NVAX Q1 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-3.98 / -	-23.018	―
Aug 06, 2026	2026 (Q2)	-7.00 / -5.89	11.417	-151.61% (-17.31)
May 06, 2026	2026 (Q1)	-4.46 / -1.10	53.954	-102.05% (-55.06)
Feb 26, 2026	2025 (Q4)	-8.93 / 2.03	-9.391	121.57% (+11.42)
Nov 06, 2025	2025 (Q3)	-22.02 / -23.02	-13.995	-64.47% (-9.02)
Aug 06, 2025	2025 (Q2)	0.15 / 11.42	18.23	-37.37% (-6.81)
May 08, 2025	2025 (Q1)	-7.79 / 53.95	-19.335	379.05% (+73.29)
Feb 27, 2025	2024 (Q4)	-9.46 / -9.39	-26.516	64.58% (+17.13)
Nov 12, 2024	2024 (Q3)	-14.57 / -13.99	-23.202	39.68% (+9.21)
Aug 08, 2024	2024 (Q2)	30.75 / 18.23	10.68	70.69% (+7.55)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed